venlafaxine hydrochloride has been researched along with s20098 in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 13 (76.47) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, E; Guilleminault, C; Lemoine, P | 1 |
| Fulton, K; Kennedy, SH; Rasmussen, J; Rizvi, S | 1 |
| Calabrese, F; Gabriel, C; Mocaer, E; Molteni, R; Racagni, G; Riva, MA | 1 |
| Girbig, D; Igl, BW; Lehmann, T; Obendorf, M; Patchev, VK; Prelle, K | 1 |
| De Berardis, D; Di Giannantonio, M; Di Iorio, G; Di Nicola, M; Gambi, F; Janiri, L; Martinotti, G; Onofrj, M; Sepede, G | 1 |
| Humpston, CS; Robinson, ES; Wood, CM | 1 |
| Bonanno, G; Bonifacino, T; Gabriel, C; Mallei, A; Milanese, M; Mocaer, E; Musazzi, L; Popoli, M; Racagni, G; Tardito, D; Treccani, G | 1 |
| de Bodinat, C; Lejoyeux, M; Matharan, S | 1 |
| Becker, T; Kösters, M; Staudigl, L | 1 |
| Brignone, M; Ereshefsky, L; Francois, C; Lançon, C; Llorca, PM; Rive, B; Salah, S | 1 |
| Brunnauer, A; Buschert, V; Distler, G; Fric, M; Laux, G; Sander, K; Segmiller, F; Zwanzger, P | 1 |
| Gavrilova, SI; Kalyn, YB; Kornilov, VV; Safarova, TP; Sheshenin, VS; Shipilova, ES; Yakovleva, OB | 1 |
| Khanam, R; Thomas, J; Vohora, D | 1 |
| Aalto-Setälä, M; Brignone, M; Campbell, R; Cure, S; Danchenko, N; Diamand, F; Hallinen, T; Kolasa, K; Koponen, H; Soini, E | 1 |
| Charoenphandhu, J; Charoenphandhu, N; Krishnamra, N; Lapmanee, S; Teerapornpuntakit, J | 1 |
| Holper, L | 1 |
2 review(s) available for venlafaxine hydrochloride and s20098
| Article | Year |
|---|---|
[If the general practitioner has to decide: what is the evidence for the selection of antidepressants?].
Topics: Acetamides; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Evidence-Based Medicine; General Practice; Germany; Guideline Adherence; Humans; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies.
Topics: Acetamides; Adult; Aged; Antidepressive Agents; Benzofurans; Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Humans; Hypnotics and Sedatives; Indoles; Male; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulfides; Thiophenes; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2014 |
5 trial(s) available for venlafaxine hydrochloride and s20098
| Article | Year |
|---|---|
Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine.
Topics: Acetamides; Adolescent; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prevalence; Sleep; Sleep Wake Disorders; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2007 |
A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR.
Topics: Acetamides; Adult; Antidepressive Agents, Second-Generation; Arousal; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Libido; Male; Middle Aged; Orgasm; Personality Inventory; Sexual Behavior; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study.
Topics: Acetamides; Adolescent; Adult; Anhedonia; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Patient Dropouts; Pilot Projects; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2012 |
How to switch to agomelatine after an unsuccessful try with paroxetine or venlafaxine.
Topics: Acetamides; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Drug Substitution; Female; Humans; Male; Middle Aged; Paroxetine; Venlafaxine Hydrochloride | 2015 |
Driving performance and psychomotor function in depressed patients treated with agomelatine or venlafaxine.
Topics: Acetamides; Adult; Automobile Driving; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychomotor Performance; Venlafaxine Hydrochloride; Visual Perception | 2015 |
10 other study(ies) available for venlafaxine hydrochloride and s20098
| Article | Year |
|---|---|
Agomelatine: new drug. Adverse effects and no proven efficacy.
Topics: Acetamides; Animals; Antidepressive Agents; Bias; Carcinogens; Clinical Trials as Topic; Cyclohexanols; Depression; Depressive Disorder; Double-Blind Method; Drug Approval; Europe; Fluoxetine; Humans; Hypnotics and Sedatives; Melatonin; Paroxetine; Psychiatric Status Rating Scales; Receptors, Melatonin; Recurrence; Selective Serotonin Reuptake Inhibitors; Suicide; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine.
Topics: Acetamides; Animals; Antidepressive Agents; Brain; Brain-Derived Neurotrophic Factor; Cyclohexanols; Cytosol; Fibroblast Growth Factor 2; Gene Expression Regulation; Neuronal Plasticity; Rats; Rats, Sprague-Dawley; Synaptosomes; Time Factors; Venlafaxine Hydrochloride | 2011 |
Endpoints of drug discovery for menopausal vasomotor symptoms: interpretation of data from a proxy of disease.
Topics: Acetamides; Amines; Animals; Body Temperature Regulation; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal; Diurnal Enuresis; Drug Discovery; Estradiol; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Hypnotics and Sedatives; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Skin Temperature; Venlafaxine Hydrochloride | 2012 |
Investigating the roles of different monoamine transmitters and impulse control using the 5-choice serial reaction time task.
Topics: Acetamides; Adrenergic alpha-2 Receptor Antagonists; Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Choice Behavior; Cyclobutanes; Cyclohexanols; Fluoxetine; Hypnotics and Sedatives; Idazoxan; Impulsive Behavior; Male; Norepinephrine; Paroxetine; Rats; Reaction Time; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2013 |
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes.
Topics: Acetamides; Analysis of Variance; Animals; Antidepressive Agents; Calcium Ionophores; Cyclohexanols; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Ionomycin; Male; Potassium Chloride; Rats; Rats, Sprague-Dawley; SNARE Proteins; Synaptosomes; Syntaxin 1; Venlafaxine Hydrochloride | 2013 |
[Optimization of the efficacy and safety of antidepressant therapy in patients of a geriatric psychiatric unit].
Topics: Acetamides; Acetylcarnitine; Aged; Antidepressive Agents; Apathy; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
Augmentation of antidepressant effects of venlafaxine by agomelatine in mice are independent of kynurenine pathway.
Topics: Acetamides; Animals; Antidepressive Agents; Depression; Drug Synergism; Female; Hindlimb Suspension; Hypnotics and Sedatives; Kynurenine; Male; Mice; Signal Transduction; Swimming; Treatment Outcome; Venlafaxine Hydrochloride | 2016 |
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland.
Topics: Acetamides; Antidepressive Agents; Bupropion; Cost-Benefit Analysis; Decision Trees; Depressive Disorder, Major; Finland; Humans; Markov Chains; Models, Theoretical; Piperazines; Recurrence; Sertraline; Sulfides; Treatment Outcome; Venlafaxine Hydrochloride; Vortioxetine | 2017 |
Agomelatine, venlafaxine, and running exercise effectively prevent anxiety- and depression-like behaviors and memory impairment in restraint stressed rats.
Topics: Acetamides; Animals; Antidepressive Agents, Second-Generation; Body Weight; Corticosterone; Depression; Feeding Behavior; Immobilization; Male; Memory Disorders; Organ Size; Physical Conditioning, Animal; Rats; Rats, Wistar; Running; Stress, Physiological; Venlafaxine Hydrochloride | 2017 |
Combining threshold analysis and GRADE to assess sensitivity to bias in antidepressant treatment recommendations adjusted for depression severity.
Topics: Acetamides; Adult; Amitriptyline; Antidepressive Agents; Bayes Theorem; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Network Meta-Analysis; Paroxetine; Publication Bias; Reproducibility of Results; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2020 |